Six decades searching for meaning in the proteome

Journal of Proteomics

Volumn 107, Issue , 2014, Pages 24-30

  Anderson, Leigh ^a  

^a SISCAPA Assay Technologies Inc   (United States)

Author keywords

Biomarker; MALDI; MRM; Plasma; Proteomics; SISCAPA

Indexed keywords

PROTEOME;

HISTORY; HUMAN; PROCEDURES; PROTEOMICS;

ANNIVERSARIES AND SPECIAL EVENTS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; PROTEOME; PROTEOMICS;

EID: 84904510910     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2014.03.005     Document Type: Review

References (33)

1. Anderson N.G. Zonal centrifuges and other separation systems. Science 1966, 154:103-112.
2. Hatcher D., Anderson N. GeMSAEC: a new analytic tool for clinical chemistry total serum protein with the biuret reaction. Am J Clin Pathol 1969, 52:645-651.
3. O'Farrell P.H. High resolution two-dimensional electrophoresis of proteins. J Biol Chem 1975, 250:4007-4021.
4. Klose J. Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues. Humangenetik 1975, 26:231-243.
5. Anderson N.L., Anderson N.G. Analytical techniques for cell fractions. XXII. Two-dimensional analysis of serum and tissue proteins: multiple gradient-slab gel electrophoresis. Anal Biochem 1978, 85:341-354.
6. Anderson L., Anderson N.G. High resolution two-dimensional electrophoresis of human plasma proteins. Proc Natl Acad Sci U S A 1977, 74:5421-5425.
7. Switzer R.C., Merril C.R., Shifrin S. A highly sensitive silver stain for detecting proteins and peptides in polyacrylamide gels. Anal Biochem 1979, 98:231-237.
8. Köhler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975, 256:495-497.
9. Anderson N., Anderson L. The human protein index. Clin Chem 1982, 28:739-748.
10. Special issue: two-dimensional electrophoresis. Clin Chem 1982, 28:737-1092.
11. Special issue: two-dimensional electrophoresis. Clin Chem 1984, 30:1897-2195.
12. Anderson N.L., Taylor J., Scandora A.E., Coulter B.P., Anderson N.G. The TYCHO system for computer analysis of two-dimensional gel electrophoresis patterns. Clin Chem 1807-1820, 1981:27.
13. Anderson N.L., Copple C.D., Bendele R.A., Probst G.S., Richardson F.C. Covalent protein modifications and gene expression changes in rodent liver following administration of methapyrilene: a study using two-dimensional electrophoresis. Fundam Appl Toxicol 1992, 18:570-580.
14. Anderson N.L., Giere F.A., Nance S.L., Gemmell M.A., Tollaksen S.L., Anderson N.G. Differences between 2-D electrophoretic protein patterns of livers of male and female mice. Electrophorese bidimensionnelle 1985, 253-260. Nancy. G. Siest (Ed.).
15. Anderson N.G., Willis D.D., Holladay D.W., Caton J.E., Holleman J.W., Eveleigh J.W., et al. Analytical techniques for cell fractions. XIX. The cyclum: an automatic system for cyclic chromatography. Anal Biochem 1975, 66:159-174.
16. Pieper R., Su Q., Gatlin C., Huang S., Anderson N., Steiner S. Multi-component immunoaffinity subtraction chromatography: an innovative step towards a comprehensive survey of the human plasma proteome. Proteomics 2003, 3:422-432.
17. Pieper R., Gatlin C.L., Makusky A.J., Russo P.S., Schatz C.R., Miller S.S., et al. The human serum proteome: display of nearly 3700 chromatographically separated protein spots on two-dimensional electrophoresis gels and identification of 325 distinct proteins. Proteomics 2003, 3:1345-1364.
18. Anderson N.L., Anderson N.G. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002, 1:845-867.
19. Anderson N.L., Hunter C.L. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol Cell Proteomics 2006, 5:573-588.
20. Anderson N.L., Anderson N.G., Haines L.R., Hardie D.B., Olafson R.W., Pearson T.W. Mass spectrometric quantitation of peptides and proteins using stable isotope standards and capture by anti-peptide antibodies (SISCAPA). J Proteome Res 2004, 3:235-244.
21. Pope M.E., Soste M.V., Eyford B.A., Anderson N.L., Pearson T.W. Anti-peptide antibody screening: selection of high affinity monoclonal reagents by a refined surface plasmon resonance technique. J Immunol Methods 2009, 341:86-96.
22. Anderson N.L., Jackson A., Smith D., Hardie D., Borchers C., Pearson T.W. SISCAPA peptide enrichment on magnetic beads using an in-line bead trap device. Mol Cell Proteomics 2009, 8:995-1005.
23. Razavi M., Frick L.E., Lamarr W.A., Pope M.E., Miller C.A., Anderson N.L., et al. High-throughput SISCAPA quantitation of peptides from human plasma digests by ultrafast, liquid chromatography-free mass spectrometry. J Proteome Res 2012, 11:5642-5649.
24. Whiteaker J.R., Zhao L., Abbatiello S.E., Burgess M., Kuhn E., Lin C., et al. Evaluation of large scale quantitative proteomic assay development using peptide affinity-based mass spectrometry. Mol Cell Proteomics 2011, 10. (M110.005645).
25. Anderson N.L. The roles of multiple proteomic platforms in a pipeline for new diagnostics. Mol Cell Proteomics 2005, 4:1441-1444.
26. Hoofnagle A.N., Becker J.O., Wener M.H., Heinecke J.W. Quantification of thyroglobulin, a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometry. Clin Chem 2008, 54:1796-1804.
27. Kushnir M.M., Rockwood A.L., Roberts W.L., Abraham D., Hoofnagle A.N., Meikle A.W. Measurement of thyroglobulin by liquid chromatography-tandem mass spectrometry in serum and plasma in the presence of antithyroglobulin autoantibodies. Clin Chem 2013, 59:982-990.
28. Anderson L. Within sight of a rational pipeline for development of protein diagnostics. Clin Chem 2011, 58:28-30.
29. Anderson N.L., Razavi M., Pearson T.W., Kruppa G., Paape R., Suckau D. The precision of heavy-light peptide ratios measured by MALDI-TOF mass spectrometry. J Proteome Res 2012, 11:1868-1878.
30. Razavi M., Johnson L.D.S., Lum J.J., Kruppa G., Anderson N.L., Pearson T.W. Quantification of a proteotypic peptide from protein C inhibitor by liquid chromatography-free SISCAPA-MALDI mass spectrometry: application to identification of recurrence of prostate cancer. Clin Chem 2013, 59:1514-1522.
31. Guthrie R., Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 1963, 32:338-343.
32. Anderson N.L. The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum. Clin Chem 2010, 56:177-185.
33. Skates S.J., Menon U., MacDonald N., Rosenthal A.N., Oram D.H., Knapp R.C., et al. Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women. J Clin Oncol 2003, 21:206s-210s.